Apollo Endosurgery Inc
NASDAQ:APEN
Apollo Endosurgery Inc
Common Shares Outstanding
Apollo Endosurgery Inc
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Apollo Endosurgery Inc
NASDAQ:APEN
|
Common Shares Outstanding
$42m
|
CAGR 3-Years
26%
|
CAGR 5-Years
19%
|
CAGR 10-Years
71%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Common Shares Outstanding
$290.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Boston Scientific Corp
NYSE:BSX
|
Common Shares Outstanding
$1.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
Stryker Corp
NYSE:SYK
|
Common Shares Outstanding
$380.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Abbott Laboratories
NYSE:ABT
|
Common Shares Outstanding
$1.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Common Shares Outstanding
$354.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
See Also
What is Apollo Endosurgery Inc's Common Shares Outstanding?
Common Shares Outstanding
42m
USD
Based on the financial report for Dec 31, 2022, Apollo Endosurgery Inc's Common Shares Outstanding amounts to 42m USD.
What is Apollo Endosurgery Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
71%
Over the last year, the Common Shares Outstanding growth was 6%. The average annual Common Shares Outstanding growth rates for Apollo Endosurgery Inc have been 26% over the past three years , 19% over the past five years , and 71% over the past ten years .